Gavin Koostachin
liked
Gavin Koostachin
voted
The tech boom fuels soaring market caps for tech giants. As of June 13, the top 3 highest market cap stocks are $MSFT.US$($3.28 trillion, 22% away from $4 trillion), $AAPL.US$($3.27 trillion, 22% away from $4 trillion), and $NVDA.US$($3.08 trillion, 25% away from $4 trillion).
The question of which firm will be the first to cross the $4 trillion market cap milestone has gained public attention ...
The question of which firm will be the first to cross the $4 trillion market cap milestone has gained public attention ...
+2
30
2
Gavin Koostachin
voted
Columns 【Moo Brief】Record-breaking surge: Apple stock soars 7% to record highs following AI announcements
$AAPL.US$ hits a record high on day 2 of WWDC. The company unveiled a long-awaited AI strategy at WWDC this year, incorporating the revolutionary "Apple Intelligence" technology across its suite of applications including Siri, and bringing OpenAI's ChatGPT to its devices.
On Tuesday, Apple witnessed a substantial surge as its shares soared by 7.3%, marking the largest single-day increase sinc...
On Tuesday, Apple witnessed a substantial surge as its shares soared by 7.3%, marking the largest single-day increase sinc...
+3
32
1
Gavin Koostachin
commented on
First published on April 19
Updated on July 3
Ensure you save this article to stay updated with our latest information, keep track of the July Financial Calendar, and seize opportunities to enhance your financial prospects.
Will Trump's Debate Performance Boost Biotech and Healthcare Stocks?
After the recent presidential debate, a potential shift in the political landscape has market analysts examining the implicati...
Updated on July 3
Ensure you save this article to stay updated with our latest information, keep track of the July Financial Calendar, and seize opportunities to enhance your financial prospects.
Will Trump's Debate Performance Boost Biotech and Healthcare Stocks?
After the recent presidential debate, a potential shift in the political landscape has market analysts examining the implicati...
+7
103
24